Spoken Alpha · Executive

Steve O'Loughlin

Chief Financial OfficerCNSPCNS Pharmaceuticals, Inc.

Current

Tracked since Mar 2, 2026

No earnings-call appearances indexed yet.

Role timeline

CNSPCNS Pharmaceuticals, Inc.
Current
Chief Financial Officer
Mar 2, 2026 – Present · source: edgar_form4
ATNMActinium Pharmaceuticals, Inc.
Chief Financial Officer
Aug 12, 2020 – Mar 31, 2025 · source: edgar_form4
ATNMActinium Pharmaceuticals, Inc.
Principal Financial Officer
Jun 15, 2017 – Jul 12, 2019 · source: edgar_form4
ATNMActinium Pharmaceuticals, Inc.
VP, Finance and Corporate Dev.
May 15, 2017 – May 15, 2017 · source: edgar_form3

Research tier

See how this executive's language deviates from their own baseline

Sign in to view the per-call Behavioral Lean, the language-deviation timeline, and the novel forward-guidance phrases flagged across this executive's earnings calls — each scored against their own prior-call history.

Sign in to view Request research access

Call appearances in our data

No earnings-call appearances indexed for this executive yet.